Novel Approach for 99mTc-Labeling of Red Blood Cells: Evaluation of 99mTc-4SAboroxime as a Blood Pool Imaging Agent
- 30 November 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 28 (12) , 2998-3006
Abstract
Angiography with radiolabeled red blood cells (RBCs) plays an important role in diagnosis and prognosis in vascular diseases. Both in vitro and in vivo methods have been developed for 99mTc-labeling of RBCs. However, these methods are complicated and lack reproducibility. Therefore, it is highly desirable to develop an alternative method for routine 99mTc-labeling of RBCs. In this report, we present a novel approach for 99mTc-labeling of RBCs. We prepared a new 99mTc(III) radiotracer [99mTcCl(CDO)(CDOH)2B-4AS] (99mTc-4ASboroxime: 4AS-B(OH)2 = 4-aminosulfonylphenyl)boronic acid, and CDOH2 = cyclohexanedione dioxime) in >95% radiochemical purity. Imaging and biodistribution studies were performed in Sprague–Dawley (SD) rats. It was found that the blood radioactivity was ∼6.0%ID/g (∼90% injected dose for 200–225 g SD rats) for 99mTc-4ASboroxime with low uptake in the myocardium, kidneys, liver, lungs, and muscle, most likely due to lack of leakage of 99mTc-labeled RBCs from the intravascular space. The blood radioactivity was almost unchanged over the 2 h period, suggesting that the binding of 99mTc-4ASboroxime to blood components (cells, proteins, and plasma) is stable. The results from γ-counting of the isolated blood components showed that 99mTc-4ASboroxime had >95% of blood radioactivity binding to RBCs, ∼1% to albumin, and ∼3% remaining free in blood plasma, demonstrating its RBC-specificity. The results from imaging studies in SD rats indicated that 99mTc-4ASboroxime is predominantly distributed in the blood pool. Main blood vessels were well delineated in the head/neck and abdominal regions. This statement was further substantiated by the results from imaging studies in pigs. 99mTc-4ASboroxime is an excellent blood pool agent with the potential for diagnosis and prognosis of vascular diseases.Keywords
Funding Information
- National Institute of Biomedical Imaging and Bioengineering (R21 EB017237-01)
- National Natural Science Foundation of China (81320108014, 81771872)
- Purdue University
This publication has 46 references indexed in Scilit:
- Does Hemodynamic Instability Predict Positive Technetium-Labeled Red Blood Cell Scintigraphy in Patients With Acute Lower Gastrointestinal Bleeding? A Review of 50 PatientsDiseases of the Colon & Rectum, 2005
- Non-invasive characterization of cardiac microvascular disease by nuclear medicine using single-photon emission tomographyHerz, 1999
- Rest and treadmill exercise first-pass radionuclide ventriculography: Validation of left ventricular ejection fraction measurementsJournal of Nuclear Cardiology, 1994
- Combined exercise radionuclide angiocardiography and single photon emission computed tomography perfusion studies for assessment of coronary artery diseaseSeminars in Nuclear Medicine, 1991
- Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variables.Circulation, 1990
- Differentiation of restrictive cardiomyopathy from pericardial constriction: Assessment of diastolic function by radionuclide angiographyJACC, 1989
- Right ventricular ejection fraction measurement: Contrast ventriculography versus gated blood pool and gated first-pass radionuclide methodsThe American Journal of Cardiology, 1984
- Local cerebral blood volume in head-injured patientsJournal of Neurosurgery, 1980
- Of linens and laces—The eighth anniversary of the gated blood pool scanSeminars in Nuclear Medicine, 1979
- Local cerebral blood volume determined by three-dimensional reconstruction of radionuclide scan data.Circulation Research, 1975